Kannaway, a subsidiary of Medical Marijuana, Inc., has partnered with nonprofit The Por Grace Foundation to provide cannabidiol (CBD) products to families in need.
Medical Marijuana, Inc., announced that its subsidiary Kannaway has expanded its operations into Hong Kong. Kannaway plans to host regional education events for current and prospective distributors about the potential benefits of hemp-derived CBD oil.
The company’s net income and net revenue increased 8% and 86% respectively year-over-year. Net revenue totaled $9.6 million for the quarter while net income reached $7 million. Gross profit for the quarter was $5.6 million.
Medical Marijuana announced that its subsidiaries HempMeds Mexico, Kannaway Japan, as well as its third-party manufacturing and distribution business, each achieved their largest revenue months in their respective histories in July 2021.
Medical Marijuana, Inc., the publicly traded parent company of direct selling company Kannaway, announced its first quarter financial results for 2021. The company reported $8.9 million in net revenue and $3.7 million in net income for the quarter, as well as a cash position of $4.9 million. “Our operations made tremendous advancements in the first […]
Medical Marijuana, Inc. announced that the Japanese division of its subsidiary Kannaway had record sales in February 2021, the best sales month in company history. “When we first entered the Japanese market in late 2019, we were one of the first companies offering cannabidiol (CBD) products in the country and saw a great opportunity to […]
Kannaway, a subsidiary of Medical Marijuana, Inc., received Certified Drug Free approval from the Banned Substances Control Group (BSCG) for its broad-spectrum CBD product Pure Gold. This third-party certification provides a stamp of approval for Pure Gold, proving that the product meets quality specifications and is not contaminated with drugs or agents that could lead to […]
Kannaway, a subsidiary of Medical Marijuana, Inc. announced it has submitted a Novel Foods application for its CBD products to the UK’s Food Standards Agency (FSA) through the European Industrial Hemp Association (EIHA) Novel Foods Consortium. “We are witnessing a pivotal moment in history when the global appetite for free access to CBD for all […]
Medical Marijuana, Inc, parent company of Kannaway, is launching a rebranding of its subsidiary HempMeds. This change comes as part of the company’s recent shift in consumer strategy and executive leadership. “As the CBD industry continues to expand exponentially throughout the world, especially in the US and Latin America, we saw an opportunity to further […]
Kannaway, a subsidiary of Medical Marijuana, Inc., the first publicly traded cannabis company in the U.S., launched Kannaway Premium CBG with Organic Hemp Seed Oil into the European cannabigerol (CBG) market. “Since launching in Europe in 2018, Europe has become one of our best revenue-generating markets as consumers have responded very positively to Kannaway’s wide […]
Medical Marijuana, Inc., the first publicly traded company in the U.S., announced its third quarter financial and operational highlights. The company generated $12.2 million in net revenue—an 11.25 percent increase compared to the previous quarter. “Our international expansion is forging ahead with full force and we will continue to further establish our company’s products as […]
Medical Marijuana, Inc. announced that its subsidiary Kannaway® has officially entered the U.S. cannabinol (CBN) market with the release of two new CBN isolate products. Not to be confused with cannabidiol (CBD), which has gained significant popularity over the past few years, CBN is another non-psychoactive cannabinoid found in the cannabis plant. Like the company’s full-spectrum CBD products, […]